ROCKVILLE, Md.--(BUSINESS WIRE)--June 13, 2006--Supernus Pharmaceuticals, Inc. announces the signing of a definitive licensing agreement with United Therapeutics Corporation for the development of UT-15C, United Therapeutics’ oral prostacyclin analog. The licensing agreement contemplates United Therapeutics’ development of UT-15C for additional indications.
